Ceftazidime Injectable (IV/IM) bulk supplier for pharma manufacturers

Ceftazidime Injectable (Iv/Im) Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV/IM)

Available Strengths: 1 g, 2 g, 2.5 g, 3 g, 4 g per vial

Reference Brands: Fortaz, Tazicef(US& EU)

Ceftazidime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against Pseudomonas aeruginosa and other gram-negative bacteria. Benefits include rapid, potent action in severe infections, broad-spectrum activity, and utility in hospital settings for pneumonia, sepsis, and complicated infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ceftazidime injectable is approved in the EU and US for treating severe bacterial infections, including pneumonia, sepsis, and complicated urinary tract infections. In the EU, brands like Fortaz are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval relies on extensive clinical data and manufacturing compliance, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers and compliance, visit PharmaTradz. We support seamless market access, ensuring adherence to European and American standards for safe, effective antibacterial therapy.

Ceftazidime Injectable (Iv/Im) — third party manufacturing & bulk supply

Ceftazidime Injectable (Iv/Im) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ceftazidime Injectable (Iv/Im) is supplied as Injectable (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ceftazidime Injectable (Iv/Im) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ceftazidime Injectable (Iv/Im) →

Back to Listing

Frequently Asked Questions

Ceftazidime is an antibiotic used to treat a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and bloodstream infections. It is especially effective against Gram-negative bacteria, including Pseudomonas aeruginosa.

Ceftazidime is made from the active pharmaceutical ingredient ceftazidime, which belongs to the third-generation cephalosporin class of antibiotics. It works by interfering with bacterial cell wall synthesis, leading to bacterial cell death.

Common trade names include Fortaz, Ceptaz, and Tazicef.

Ceftazidime is manufactured by multiple pharmaceutical companies worldwide. The original brand Fortaz is marketed by GlaxoSmithKline (GSK) in some regions, while generic versions are produced by various other manufacturers.

The generic name is ceftazidime.

Brand names include Fortaz, Ceptaz, and Tazicef, along with multiple regional generics.

Ceftazidime is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, India, and other countries depending on the manufacturer and marketing authorization holder.